Abstract
An assay has been developed for specific measurement of two different lipase activities in postheparin plasma. Lipoprotein lipase, derived from extrahepatic sources, is measured as protamine-inactivated lipase activity; hepatic lipase activity is protamine-resistant under the conditions of this assay. In 100 normal subjects, both enzyme activities were noted to be related to age and sex. Protamine-resistant lipase, which comprised 46-95% of the total activity, was highest in men over 18. Protamine-inactivated lipase activity was greatest in younger males and was age-correlated in women, doubling between the second and sixth decades.
In 12 patients with hyperchylomicronemia, including five previously shown to have familial type I hyperlipoproteinemia, protamine-inactivated lipase activity was markedly reduced, whereas protamine-resistant lipase was below normal in only 1. The results were not due to lack of plasma activator, presence of plasma inhibitor, or diet, and the deficiency was not overcome by increasing the provoking dose of heparin from 10 U to 75 U/kg. Mean values for both lipase activities were not reduced in 32 other patients with hyperchylomicronemia, nine with “floating beta” lipoproteins (type III hyperlipoproteinemia), and 23 with hyperprebetalipoproteinemia (type IV). Mean protamine-resistant lipase activity was below normal in a group of four women with hypothyroidism, in whom protamine-inactivated lipase was not reduced. Both of the lipase activities were capable of hydrolyzing lipid in very low-density lipoproteins, but the relative rate of hydrolysis of chylomicrons by protamine-resistant lipase was markedly limited. These results indicate the importance of distinguishing between lipases of hepatic and extra-hepatic origin in the measurement of postheparin lipolytic activity.
Full text
PDF

















Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Assmann G., Krauss R. M., Fredrickson D. S., Levy R. I. Characterization, subcellular localization, and partial purification of a heparin-released triglyceride lipase from rat liver. J Biol Chem. 1973 Mar 25;248(6):1992–1999. [PubMed] [Google Scholar]
- Assmann G., Krauss R. M., Fredrickson D. S., Levy R. I. Positional specificity of triglyceride lipases in post-heparin plasma. J Biol Chem. 1973 Oct 25;248(20):7184–7190. [PubMed] [Google Scholar]
- BARCLAY M., GARFINKEL E., TEREBUS-KEKISH O., SHAH E. B., DEGUIA M., BARCLAY R. K., SKIPSKI V. P. Properties of lipoprotein lipase extracted from livers of normal rats and livers and tumors of rats bearing Walker carcinosarcoma 256. Arch Biochem Biophys. 1962 Sep;98:397–405. doi: 10.1016/0003-9861(62)90204-7. [DOI] [PubMed] [Google Scholar]
- BOBERG J., CARLSON L. A. DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA. Clin Chim Acta. 1964 Nov;10:420–427. doi: 10.1016/0009-8981(64)90171-8. [DOI] [PubMed] [Google Scholar]
- Bagdade J. D., Hazzard W. R., Carlin J. Effect of unsaturated dietary fat on plasma lipoprotein lipase activity in normal and hyperlipidemic states. Metabolism. 1970 Dec;19(12):1020–1024. doi: 10.1016/0026-0495(70)90025-9. [DOI] [PubMed] [Google Scholar]
- Bagdade J. D., Porte D., Jr, Bierman E. L. Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med. 1967 Feb 23;276(8):427–433. doi: 10.1056/NEJM196702232760802. [DOI] [PubMed] [Google Scholar]
- Bagdade J. D., Porte D., Jr, Bierman E. L. Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N Engl J Med. 1968 Jul 25;279(4):181–185. doi: 10.1056/NEJM196807252790403. [DOI] [PubMed] [Google Scholar]
- Bagdade J. D., Porte D., Jr, Bierman E. L. Steroid-induced lipemia. A complication of high-dosage corticosteroid therapy. Arch Intern Med. 1970 Jan;125(1):129–134. doi: 10.1001/archinte.125.1.129. [DOI] [PubMed] [Google Scholar]
- Baylin S. B., Beaven M. A., Krauss R. M., Keiser H. R. Response of plasma histaminase activity to small doses of heparin in normal subjects and patients with hyperlipoproteinemia. J Clin Invest. 1973 Aug;52(8):1985–1993. doi: 10.1172/JCI107383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Belfrage P. Metabolism of chyle triglycerides in the liver. I. Studies on the mechanisms for liver uptake of intravenously injected, glycerol- and fatty acid-labeled chyle in the carbohydrate-fed rat. Biochim Biophys Acta. 1966 Dec 7;125(3):474–484. [PubMed] [Google Scholar]
- Bergman E. N., Havel R. J., Wolfe B. M., Bohmer T. Quantitative studies of the metabolism of chylomicron triglycerides and cholesterol by liver and extrahepatic tissues of sheep and dogs. J Clin Invest. 1971 Sep;50(9):1831–1839. doi: 10.1172/JCI106674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Biale Y., Shafrir E. Lipolytic activity toward tri- and monoglycerides in postheparin plasma. Clin Chim Acta. 1969 Mar;23(3):413–419. doi: 10.1016/0009-8981(69)90341-6. [DOI] [PubMed] [Google Scholar]
- Bradford R. H., Furman R. H., Bass H. B. Plasma post-heparin lipolytic activity in hyperchylomi-cronemia (fat-induced lipemia). Biochim Biophys Acta. 1968 Oct 22;164(2):172–184. doi: 10.1016/0005-2760(68)90144-6. [DOI] [PubMed] [Google Scholar]
- Brown W. V., Levy R. I., Fredrickson D. S. Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem. 1969 Oct 25;244(20):5687–5694. [PubMed] [Google Scholar]
- Brunzell J. D., Hazzard W. R., Porte D., Jr, Bierman E. L. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973 Jul;52(7):1578–1585. doi: 10.1172/JCI107334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CONDON R. E., TOBIAS H., DATTA D. V. THE LIVER AND POSTHEPARIN PLASMA LIPOLYTIC ACTIVITY IN DOG AND MAN. J Clin Invest. 1965 May;44:860–869. doi: 10.1172/JCI105198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carlson L. A., Eriksson I., Walldius G. A case of massive hypertriglyceridaemia and impaired fatty acid incorporation into adipose tissue glycerides (FIAT), both corrected by nicotinic acid. Acta Med Scand. 1973 Nov;194(5):363–369. doi: 10.1111/j.0954-6820.1973.tb19460.x. [DOI] [PubMed] [Google Scholar]
- DOLE V. P., MEINERTZ H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 1960 Sep;235:2595–2599. [PubMed] [Google Scholar]
- FREDRICKSON D. S., ONO K., DAVIS L. L. LIPOLYTIC ACTIVITY OF POST-HEPARIN PLASMA IN HYPERGLYCERIDEMIA. J Lipid Res. 1963 Jan;4:24–33. [PubMed] [Google Scholar]
- Felts J. M., Berry M. N. The metabolism of free fatty acids and chylomicron triglyceride fatty acids by isolated rat liver cells. Biochim Biophys Acta. 1971 Feb 2;231(1):1–7. doi: 10.1016/0005-2760(71)90249-9. [DOI] [PubMed] [Google Scholar]
- Fielding C. J. Further characterisation of lipoprotein lipase and hepatic post-heparin lipase from rat plasma. Biochim Biophys Acta. 1972 Dec 8;280(4):569–578. doi: 10.1016/0005-2760(72)90137-3. [DOI] [PubMed] [Google Scholar]
- Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 19;276(3):148–contd. doi: 10.1056/NEJM196701192760305. [DOI] [PubMed] [Google Scholar]
- Garfinkel A. S., Baker N., Schotz M. C. Relationship of lipoprotein lipase activity to triglyceride uptake in adipose tissue. J Lipid Res. 1967 May;8(3):274–280. [PubMed] [Google Scholar]
- Glueck C. J., Ford S., Jr, Steiner P., Fallat R. Triglyceride removal efficiency and lipoprotein lipases: effects of Oxandrolone. Metabolism. 1973 Jun;22(6):807–814. doi: 10.1016/0026-0495(73)90051-6. [DOI] [PubMed] [Google Scholar]
- Glueck C. J., Kaplan A. P., Levy R. I., Greten H., Gralnick H., Fredrickson D. S. A new mechanism of exogenous hyperglyceridemia. Ann Intern Med. 1969 Dec;71(6):1051–1062. doi: 10.7326/0003-4819-71-6-1051. [DOI] [PubMed] [Google Scholar]
- Glueck C. J., Levy R. I., Fredrickson D. S. Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons. Ann Intern Med. 1971 Sep;75(3):345–352. doi: 10.7326/0003-4819-75-3-345. [DOI] [PubMed] [Google Scholar]
- Gochman N., Schmitz J. M. Application of a new peroxide indicator reaction to the specific, automated determination of glucose with glucose oxidase. Clin Chem. 1972 Sep;18(9):943–950. [PubMed] [Google Scholar]
- Greten H., Levy R. I., Fredrickson D. S. Evidence for separate monoglyceride hydrolase and triglyceride lipase in post-heparin human plasma. J Lipid Res. 1969 May;10(3):326–330. [PubMed] [Google Scholar]
- HAVEL R. J., GORDON R. S., Jr Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest. 1960 Dec;39:1777–1790. doi: 10.1172/JCI104202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harlan W. R., Jr, Winesett P. S., Wasserman A. J. Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat. J Clin Invest. 1967 Feb;46(2):239–247. doi: 10.1172/JCI105526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Havel R. J., Kane J. P., Balasse E. O., Segel N., Basso L. V. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest. 1970 Nov;49(11):2017–2035. doi: 10.1172/JCI106422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Havel R. J. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med. 1969;15:117–154. [PubMed] [Google Scholar]
- Havel R. J., Shore V. G., Shore B., Bier D. M. Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase. Circ Res. 1970 Oct;27(4):595–600. doi: 10.1161/01.res.27.4.595. [DOI] [PubMed] [Google Scholar]
- Hazzard W. R., Notter D. T., Spiger M. J., Bierman E. L. Oral contraceptives and triglyceride transport: acquired heparin resistance as the mechanism for impaired post-heparin lipolytic activity. J Clin Endocrinol Metab. 1972 Sep;35(3):425–437. doi: 10.1210/jcem-35-3-425. [DOI] [PubMed] [Google Scholar]
- Hazzard W. R., Spiger M. J., Bagdade J. D., Bierman E. L. Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. N Engl J Med. 1969 Feb 27;280(9):471–474. doi: 10.1056/NEJM196902272800904. [DOI] [PubMed] [Google Scholar]
- Higgins J. A., Green C. Properties of a lipase of rat-liver parenchymal cells. Biochim Biophys Acta. 1967 Oct 2;144(2):211–220. doi: 10.1016/0005-2760(67)90151-8. [DOI] [PubMed] [Google Scholar]
- KESSLER J. I., KNIFFEN J. C., JANOWITZ H. D. LIPOPROTEIN LIPASE INHIBITION IN THE HYPERLIPEMIA OF ACUTE ALCOHOLIC PANCREATITIS. N Engl J Med. 1963 Oct 31;269:943–948. doi: 10.1056/NEJM196310312691803. [DOI] [PubMed] [Google Scholar]
- KORN E. D. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 1955 Jul;215(1):1–14. [PubMed] [Google Scholar]
- KORN E. D. Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J Biol Chem. 1955 Jul;215(1):15–26. [PubMed] [Google Scholar]
- Kessler G., Pileggi V. J. A semiautomated nonincineration technique for determining serum thyroxine. Clin Chem. 1970 May;16(5):382–389. [PubMed] [Google Scholar]
- Krauss R. M., Herbert P. N., Levy R. I., Fredrickson D. S. Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ Res. 1973 Oct;33(4):403–411. doi: 10.1161/01.res.33.4.403. [DOI] [PubMed] [Google Scholar]
- Krauss R. M., Windmueller H. G., Levy R. I., Fredrickson D. S. Selective measurement of two different triglyceride lipase activities in rat postheparin plasma. J Lipid Res. 1973 May;14(3):286–295. [PubMed] [Google Scholar]
- LOSOWSKY M. S., JONES D. P., DAVIDSON C. S., LIEBER C. S. STUDIES OF ALCOHOLIC HYPERLIPEMIA AND ITS MECHANISM. Am J Med. 1963 Dec;35:794–803. doi: 10.1016/0002-9343(63)90241-9. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- LaRosa J. C., Levy R. I., Herbert P., Lux S. E., Fredrickson D. S. A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun. 1970 Oct 9;41(1):57–62. doi: 10.1016/0006-291x(70)90468-7. [DOI] [PubMed] [Google Scholar]
- LaRosa J. C., Levy R. I., Windmueller H. G., Fredrickson D. S. Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma. J Lipid Res. 1972 May;13(3):356–363. [PubMed] [Google Scholar]
- Mayes P. A., Felts J. M. The functional status of lipoprotein lipase in rat liver. Biochem J. 1968 Jul;108(3):483–487. doi: 10.1042/bj1080483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nestel P. J., Havel R. J., Bezman A. SITES OF INITIAL REMOVAL OF CHYLOMICRON TRIGLYCERIDE FATTY ACIDS FROM THE BLOOD. J Clin Invest. 1962 Oct;41(10):1915–1921. doi: 10.1172/JCI104648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PORTE D., Jr, WILLIAMS R. H. POST-HEPARIN LIPOLYTIC ACTIVITY FOLLOWING INTRAVENOUS HEPARIN-S35. Proc Soc Exp Biol Med. 1965 Mar;118:639–643. doi: 10.3181/00379727-118-29926. [DOI] [PubMed] [Google Scholar]
- Persson B. Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature. Acta Med Scand. 1973 May;193(5):457–462. doi: 10.1111/j.0954-6820.1973.tb10608.x. [DOI] [PubMed] [Google Scholar]
- Porte D., Jr, O'Hara D. D., Williams R. H. The relation between postheparin lipolytic activity and plasma triglyceride in myxedema. Metabolism. 1966 Feb;15(2):107–113. doi: 10.1016/0026-0495(66)90031-x. [DOI] [PubMed] [Google Scholar]
- Quarfordt S. H., Frank A., Shames D. M., Berman M., Steinberg D. Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets. J Clin Invest. 1970 Dec;49(12):2281–2297. doi: 10.1172/JCI106448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quarfordt S., Levy R. I., Fredrickson D. S. On thelipoprotein abnormality in type 3 hyperlipoproteinemia. J Clin Invest. 1971 Apr;50(4):754–761. doi: 10.1172/JCI106546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Redgrave T. G. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J Clin Invest. 1970 Mar;49(3):465–471. doi: 10.1172/JCI106255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schotz M. C., Arnesjö B., Olivecrona T. The role of the liver in the uptake of plasma and chyle triglycerides in the rat. Biochim Biophys Acta. 1966 Dec 7;125(3):485–495. doi: 10.1016/0005-2760(66)90037-3. [DOI] [PubMed] [Google Scholar]
- Schotz M. C., Garfinkel A. S., Huebotter R. J., Stewart J. E. A rapid assay for lipoprotein lipase. J Lipid Res. 1970 Jan;11(1):68–69. [PubMed] [Google Scholar]
- Schreibman P. H., Arons D. L., Saudek C. D., Arky R. A. Abnormal lipoprotein lipase in familial exogenous hypertriglyceridemia. J Clin Invest. 1973 Aug;52(8):2075–2082. doi: 10.1172/JCI107392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steiner G. Lipoprotein lipase in fat-induced hyperlipemia. N Engl J Med. 1968 Jul 11;279(2):70–74. doi: 10.1056/NEJM196807112790204. [DOI] [PubMed] [Google Scholar]
- VOGEL W. C., ZIEVE L. POST-HEPARIN PHOSPHOLIPASE. J Lipid Res. 1964 Apr;5:177–183. [PubMed] [Google Scholar]
- Vogel W. C., Bierman E. L. Post-heparin serum lecithinase in man and its positional specificity. J Lipid Res. 1967 Jan;8(1):46–53. [PubMed] [Google Scholar]